Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 5 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT03424941Not ApplicableCompleted

The TransCatheter Valve and Vessels Trial

Role: lead

NCT04753372Completed

Rivaroxaban Plus Aspirin in Patients With Chronic Coronary Syndrome and High Ischemic Risk

Role: lead

NCT03845010Not ApplicableCompleted

Elimination of VPB With Ablation Versus Anti-arrhythmic Drug Treatment

Role: lead

NCT04837404Not ApplicableCompleted

Ultrasound Guided Transfemoral Complex Large-bore PCI Trial

Role: lead

NCT03846752Not ApplicableCompleted

Complex Large-bore Radial Percutaneous Coronary Intervention (PCI) Trial

Role: lead

All 5 trials loaded